Plasmodium berghei: in vivo efficacy of albendazole in different rodent models.
Dow
G S
GS
Institute for Molecular Genetics and Animal Disease, Murdoch University, Australia.
Reynoldson
J A
JA
Thompson
R C
RC
D015766:Albendazole / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D000962:Antimalarials / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D015415:Biomarkers / Q000737:chemistry; D002738:Chloroquine / Q000494:pharmacology / Q000627:therapeutic use; D017608:Chromium Compounds / Q000493:pharmacokinetics; D004195:Disease Models, Animal; D005772:Gastrointestinal Transit; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar
D000871:Anthelmintics; D000962:Antimalarials; D015415:Biomarkers; D017608:Chromium Compounds; C053245:chromium dioxide; D002738:Chloroquine; D015766:Albendazole